JNJ

2024Q2BMO

Johnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-07-17 · Fiscal end 2024-06-30 · Features as of 2024-07-16

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.70
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2024-07-16

Run-up

Close—
Ret 5d+2.7%
Ret 10d+3.1%
Ret 20d+3.8%
Ret 30d+3.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.82Beat
Estimated EPS2.70
Actual revenue
22.4B
Surprise %+4.4%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+3.3%
Implied vs actual

Implied 2.0%Actual 0.4%

Gap reaction+0.4%
Day result+3.7%
Next-day upYes
Realized / IV0.18×

Post tape

Post 5d-0.2%
Post 10d+0.8%
Post volume13.8M
Vol ×10d2.48×
Vol ×20d2.08×
Post range4.0%